Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00077935 · ClinicalTrials.gov registry record · Phase 3
Civamide in OA of the Knee(s)
A Phase 3 study of Osteoarthritis, Knee, sponsored by Winston Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 351
- Enrollment target
- 20
- Study locations
NCT00077935 is a Phase 3 study of Osteoarthritis, Knee that has completed, run by Winston Laboratories. The registered enrollment target is 351 participants, below the 576-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (39% lower). The trial reports 20 study locations across 14 states.
The verdict
NCT00077935, a Phase 3 study of Osteoarthritis, Knee, has completed, sponsored by Winston Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 351 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to evaluate the safety of Civamide Cream 0.075% as a Treatment in Subjects with Osteoarthritis (OA) of the Knee(s).
Conditions Studied
Interventions
- DRUG Civamide
Study Locations (20)
Florida
- Radiant Research - Daytona Beach
- University Clinical Research - DeLand
- Robert W. Levin, MD - Dunedin
- University Clinical Research Inc. - Pembroke Pines
California
- OMC Clinical Research Center - Beverly Hills
- Med. Investigations - Fair Oaks
- Boling Clinical Trials - Rancho Cucamonga
Missouri
- Center for Pharmaceutical Research - Kansas City
- Medex Healthcare Research Inc. - St Louis
Alabama
- Innovative Clinical Trials - Birmingham
Arizona
- University of Arizona - Tucson
Georgia
- Radiant Research - Atlanta
Idaho
- Radiant Research - Boise
Illinois
- Feinberg School of Medicine/Office of Clinical Rsrch and Trng - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 351 participants |
| Start Date | 2003-11 |
| Est. Completion | 2005-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00077935
The ClinicalTrials.gov registry entry for NCT00077935 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 351 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 576-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (39% lower). The listed sponsor is Winston Laboratories, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which Civamide is the first listed.
NCT00077935 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Florida, California, Missouri.
Frequently Asked Questions
What is clinical trial NCT00077935 about?
NCT00077935 is a clinical study titled "Civamide in OA of the Knee(s)". The purpose of this study is to evaluate the safety of Civamide Cream 0.075% as a Treatment in Subjects with Osteoarthritis (OA) of the Knee(s).
What is the current status of trial NCT00077935?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 351 participants. The study started on 2003-11. Estimated completion is 2005-07.
What conditions does trial NCT00077935 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee.
What interventions are being tested in trial NCT00077935?
The interventions under investigation include: Civamide (DRUG).
Who is sponsoring clinical trial NCT00077935?
This trial is sponsored by Winston Laboratories, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00077935 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
RECRUITING · Phase 3
-
Rehabilitation for Arthritis of The Knee: mainTaining Improvement for Veterans
RECRUITING · Phase 3
-
A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms
ACTIVE NOT RECRUITING · Phase 3
-
Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
ACTIVE NOT RECRUITING · Phase 3
-
Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.